Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts

Journal of Clinical Psychopharmacology

Volumn 18, Issue 5, 1998, Pages 384-389

  Bocchetta, Alberto ^a   Ardau, Raffaella ^a   Burrai, Caterina ^a   Chillotti, Caterina ^a   Quesada, Giorgia ^a   Del Zompo, Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; LITHIUM CARBONATE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK MANAGEMENT; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; AGED; ANTIMANIC AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; ITALY; LITHIUM CARBONATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK; SUBSTANCE WITHDRAWAL SYNDROME; SUICIDE; SUICIDE, ATTEMPTED;

EID: 0031691243     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199810000-00006     Document Type: Article

References (24)

1. Jamison KR. Suicide in manic-depressive illness. In: Goodwin FK, Jamison KR, eds. Manic-depressive illness. London: Oxford University Press, 1990:227-44.
2. Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry 1970;117:437-8.
3. Angst J, Preisig M. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients: results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 1995;146: 17-23.
4. Fawcett J, Scheftner WA, Fogg L, Clarke D, Young M, Hedeker D, Gibbons R. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990;147:1189-94.
5. Nordström P, Åsberg M, Åberg-Wistedt A, Nordin C. Attempted suicide predicts suicide risk in mood disorders. Acta Psychiatr Scand 1995;92:345-50.
6. NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Am J Psychiatry 1985;142:469-76.
7. Müller-Oerlinghausen B, Müser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992;25:261-70.
8. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiatry 1996; 29:103-7.
9. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
10. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria for a selected group of functional disorders. 3rd ed. New York: New York State Psychiatric Institute, 1977.
11. Müller-Oerlinghausen B, Ahrens B, Volk J, Grof P, Grof E, Schou M, Vestergaard P, Lenz G, Simhandl C, Thau K, Wolf R. Reduced mortality of manic-depressive patients in long-term lithium treatment: an international collaborative study by IGSLI. Psychiatry Res 1991;36:329-31.
12. Nilsson A, Axelsson R. Factors associated with discontinuation of long-term lithium treatment. Acta Psychiatr Scand 1989;80: 221-30.
13. Hetmar O, Porlvsen UJ, Ladefoged J, Bolwig TJ. Lithium long-term effects on the kidney: a prospective follow-up study ten years after kidney biopsy. Br J Psychiatry 1991;158:53-8.
14. Isometsä E, Henriksson M, Lönnqvist J. Completed suicide and recent lithium treatment. J Affect Disord 1992;26:101-4.
15. Tsuang MT. Risk of suicide in the relatives of schizophrenics, manics, depressives, and controls. J Clin Psychiatry 1983;44: 396-400.
16. Egeland JA, Sussex JN. Suicide and family loading for affective disorders. JAMA 1985;254:915-8.
17. Montgomery SA, Montgomery D. Pharmacological prevention of suicide behavior. J Affect Disord 1982;4:291-8.
18. Coccaro EF, Siever LJ. The neuropsychopharmacology of personality disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995:1567-79.
19. Sheard MH, Marini JL, Bridges CI, Wagner E. The effects of lithium on impulsive aggressive behavior in man. Am J Psychiatry 1976;133:1409-13.
20. Manji HK, Potter WZ, Lenox RH. Signal transduction pathways: molecular targets for lithium's action. Arch Gen Psychiatry 1995; 52:531-43.
21. Jope RS, Song L, Li PP, Young LT, Kish SJ, Pacheco MA, Warsh JJ. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J Neurochem 1996;66:2402-9.
22. Pacheco MA, Stockmeier C, Meltzer HJ, Overholser JC, Dilley GE, Jope RS. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res 1996;723:37-45.
23. Bocchetta A, Chillotti C, Severino G, Ardau R, Del Zompo M. Carbamazepine augmentation in lithium-refractory bipolar patients: a prospective study on long-term prophylactic effectiveness. J Clin Psychopharmacol 1997;17:92-6.
24. Schou M. Forty years of lithium treatment. Arch Gen Psychiatry 1997;54:9-13.